Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

New approach to create treatments for osteoporosis, autoimmune diseases

Scientists have developed an approach to creating treatments for osteoporosis and autoimmune diseases that may avoid the risk of infection and cancer posed by some current medications.

26 Sep 2014

Viewpoints: A 'success story' in McAllen, Texas; 'uniquely high prices' in health care

It may have been the most influential magazine article of the past decade. In June of 2009, the doctor and writer Atul Gawande published a piece in The New Yorker called "The Cost Conundrum," which examined why the small border city of McAllen, Tex., was the most expensive place for health care in the United States. ... Five years later, the situation has changed. Where McAllen once illustrated the problem of American health care, the city is now showing us how the problem can be solved, largely because of the Affordable Care Act that Mr. Obama signed into law in 2010 (Bob Kocher and Farzad Mostashari, 9/23).

25 Sep 2014

TSRI scientists awarded DARPA grant to build artificial immune system

Scientists from both campuses of The Scripps Research Institute have been awarded a total of $7.9 million from the Defense Advanced Research Projects Agency of the U.S. Department of Defense.

25 Sep 2014

NIH awards grants to 11 research groups to establish AMP RA/Lupus Network

The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network.

25 Sep 2014

New findings raise hope for novel class of drugs to treat lupus

New findings by a biomedical engineer and his team at the University of Houston raise hope for a new class of drugs to treat lupus that may not include the long list of adverse risks and side effects often associated with current treatments for this disease.

25 Sep 2014

Studies explain why some people are at greater risk for ACL injury than others

The successful rise and fall of an athlete's moving body relies on an orchestrated response of bones, joints, ligaments and tendons, putting the many angles and intersecting planes - literally the geometry - of a critical part like a knee joint to the test. But it's more than just a footfall error at the root of one of the most devastating of sports injuries: the ACL or anterior cruciate ligament tear.

24 Sep 2014

eSSENTIAL Accessibility, Aeroplan partner to offer desktop app for people with physical disabilities

eSSENTIAL Accessibility is proud to announce its partnership with Aeroplan, Canada's premier coalition loyalty program.

23 Sep 2014

ACP and 20 other groups applaud Senate bill that ensures primary care access for women, children

The efforts and leadership of Senators Sherrod Brown (D-Ohio) and Patty Murray (D-Wash.) to ensure access to vital primary care services were lauded yesterday by the American College of Physicians and 20 other organizations, representing internal medicine and related subspecialties.

23 Sep 2014

Neuropathic pain phenotype identified in knee osteoarthritis

Some patients with knee osteoarthritis may experience neuropathic-like symptoms associated with central pain processing, reflecting a discrete phenotype, study findings suggest.

22 Sep 2014

Metabolic abnormalities predict severe hypertension

Components of the metabolic syndrome, as well as a family history of hypertension, identify people at risk of developing severe hypertension, say researchers.

22 Sep 2014

EYLEA Injection gets approval in Japan for treatment of myopic CNV

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare for EYLEA (aflibercept) Injection for myopic choroidal neovascularization (myopic CNV).

22 Sep 2014

TSRI scientists devise new vancomycin-based antibiotic to rout resistant bacteria

Scientists at The Scripps Research Institute have devised a new antibiotic based on vancomycin that is powerfully effective against vancomycin-resistant strains of MRSA and other disease-causing bacteria.

18 Sep 2014

Researchers show link between childhood asthma and prenatal exposure to phthalates

Researchers at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health are the first to demonstrate an association between childhood asthma and prenatal exposure to two phthalates used in a diverse array of household products. Results appear online in the journal Environmental Health Perspectives.

18 Sep 2014

Fat mass contributes to musculoskeletal pain risk

People with high fat mass could be at an increased risk of musculoskeletal pain, say researchers.

17 Sep 2014

Age confounds relationship between ambulatory and office BP

The relationship between ambulatory and office blood pressure varies with age, with the likelihood of white-coat hypertension increasing as people get older, a study shows.

17 Sep 2014

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co., Ltd for the development, manufacturing and marketing in Mainland China of PEG-irinotecan, a long-acting polymer-drug conjugate which inhibits topoisomerase I (Topo-I).

17 Sep 2014

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.

16 Sep 2014

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).

16 Sep 2014

Patients with particular genetic variation more prone to drug-induced pancreatitis

Doctors have discovered that patients with a particular genetic variation are four times more likely to develop pancreatitis if they are prescribed a widely used group of drugs.

16 Sep 2014

GILZ protein key to preventing bone loss, researchers report

A small protein named GILZ appears to protect against the bone loss that often accompanies arthritis and its treatment, researchers report.

15 Sep 2014

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

New approach to create treatments for osteoporosis, autoimmune diseases

Viewpoints: A 'success story' in McAllen, Texas; 'uniquely high prices' in health care

TSRI scientists awarded DARPA grant to build artificial immune system

NIH awards grants to 11 research groups to establish AMP RA/Lupus Network

New findings raise hope for novel class of drugs to treat lupus

Studies explain why some people are at greater risk for ACL injury than others

eSSENTIAL Accessibility, Aeroplan partner to offer desktop app for people with physical disabilities

ACP and 20 other groups applaud Senate bill that ensures primary care access for women, children

Neuropathic pain phenotype identified in knee osteoarthritis

Metabolic abnormalities predict severe hypertension

EYLEA Injection gets approval in Japan for treatment of myopic CNV

TSRI scientists devise new vancomycin-based antibiotic to rout resistant bacteria

Researchers show link between childhood asthma and prenatal exposure to phthalates

Fat mass contributes to musculoskeletal pain risk

Age confounds relationship between ambulatory and office BP

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Patients with particular genetic variation more prone to drug-induced pancreatitis

GILZ protein key to preventing bone loss, researchers report

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in